Trident Texofab Limited has announced that its board of directors will meet on Thursday, May 28, 2026. The primary agenda for the meeting is to consider and approve the audited standalone financial results for the quarter and financial year ended March 31, 2026.

Board Meeting Agenda

The meeting, scheduled to be held at the company's registered office, will deliberate upon the financial performance for the fourth quarter of fiscal year 2026 and the full fiscal year. The board will also consider any other business with the permission of the chair.

Trading Window Closure

In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the company's equity shares has been closed since April 1, 2026. This measure is part of the company's code of conduct to prevent insider trading during the period leading up to the financial results announcement.

The window is scheduled to reopen 48 hours after the results of the board meeting are made public on May 28, 2026.

Trident Texofab Limited has issued a formal response to BSE Limited regarding inquiries about significant movement in its share price, clarifying that no undisclosed material information is affecting the stock's performance.

Company's Official Response to BSE

In a communication dated April 16, 2026, Trident Texofab addressed BSE's letter dated April 15, 2026, which sought clarification on the notable price movement of the company's shares. The response was signed by Rahul Jariwala, Company Secretary and Compliance Officer.

Regulatory Compliance and Disclosure Status

The company emphasized its commitment to regulatory compliance, stating that all material information and announcements that may impact operations or performance have been consistently disclosed. Trident Texofab confirmed adherence to the following regulatory frameworks:

• Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
• Insider trading regulations
• Timely disclosure requirements within stipulated timeframes

Market-Driven Price Movement

Triden Texofab categorically stated that the recent share price movement is purely attributable to market conditions and market-driven factors. The company clarified that it neither has control over such price movements nor possesses knowledge of the specific reasons behind the volatility.

The textile manufacturer confirmed that there is no pending information or announcement that could have a bearing on the company's share price movement, reinforcing transparency in its communication with stakeholders.

Corporate Communication Details

The official response was digitally signed by Rahul Jariwala, Company Secretary and Compliance Officer (Membership No: A70164), on April 16, 2026, at 16:47:14 +05'30'. This formal communication ensures proper documentation and regulatory compliance in addressing BSE's inquiry about the share price movement.